International Journal of Drug Policy
Volume 16, Issue 3 , Pages 176-182 , June 2005

Modelling the characteristics of the male injecting drug user population in England and Wales

  • Andrew J. Sutton

      Affiliations

    • Health Protection Agency, Statistics, Modelling and Economics Unit, Colindale, London, UK
    • Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 20 8200 6868x4421; fax: +44 20 8200 7868.
  • ,
  • Nigel J. Gay

      Affiliations

    • Health Protection Agency, Statistics, Modelling and Economics Unit, Colindale, London, UK
  • ,
  • W. John Edmunds

      Affiliations

    • Health Protection Agency, Statistics, Modelling and Economics Unit, Colindale, London, UK
  • ,
  • Nick J. Andrews

      Affiliations

    • Health Protection Agency, Statistics, Modelling and Economics Unit, Colindale, London, UK
  • ,
  • Vivian D. Hope

      Affiliations

    • Health Protection Agency, HIV & STI Division, Colindale, London, UK
    • Centre for Research on Drugs & Health Behaviour, Imperial College, London, UK
  • ,
  • O. Noel Gill

      Affiliations

    • Health Protection Agency, HIV & STI Division, Colindale, London, UK

Received 7 July 2004 ,Revised 1 October 2004 ,Accepted 4 October 2004.

References 

  1. Armitage, P., & Colton, T. (1998). Encyclopedia of biostatistics, Vol. 5: PRI-SPH. London: Wiley.
  2. Coid, J., Carvell, A., Kittler, Z., Healey, A., & Henderson, J. (2000). Opiates, criminal behaviour, and methadone treatment (Rep. No. 120). London: Home Office.
  3. Cook PA, McVeigh J, Syed Q, Mutton K, Bellis MA. Predictors of Hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction. 2001;96:1787–1797
  4. Frischer M, Hickman M, Kraus L, Mariani F, Wiessing L. A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain. Addiction. 2001;96:1465–1476
  5. Godfrey, C., Eaton, G., McDougall, C., & Culyer, A. (2002). The economic and social costs of class A drug use in England and Wales, 2000 (Vol. 249). Home Office.
  6. Health Protection Agency. (2003). The Unlinked Anonymous Prevalence Monitoring Programme. Website [Announcement posted on the World Wide Web]. Available from the World Wide Web: http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/hiv/epidemiology/ua.htm.
  7. Hickman M, Seaman S, de Angelis D. Estimating the relative incidence of heroin use: application of a method for adjusting observed reports of first visits to specialized drug treatment agencies. American Journal of Epidemiology. 2001;153:632–641
  8. Home Office. (2002). Updated drug strategy 2002. Stationary Office.
  9. Hope VD, Rogers PA, Jordan L, Paine TC, Barnett S, Parry JV, et al. Sustained increase in the sharing of needles and syringes among drug users in England and Wales. AIDS. 2002;16:2494–2496
  10. Hunter GM, Stimson GV, Judd A, Jones S, Hickman M. Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England. Addiction. 2000;95:1351–1361
  11. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet. 2001;358:1835–1842
  12. Johnson AM, Wadsworth J, Wellings K, Field J. Sexual attitudes and lifestyles. 1st ed.. Blackwell Scientific Publications; 1994;
  13. Nicoll A, Gill ON, Peckham CS, Ades AE, Parry J, Mortimer P, et al. The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom. International Journal of Epidemiology. 2000;29:1–10
  14. Unlinked Anonymous Surveys Steering Group. (2002). Prevalence of HIV and hepatitis infections in the United Kingdom 2001. Annual report of the Unlinked Anonymous Prevalence Monitoring Programme, Department of Health.

PII: S0955-3959(04)00124-0

doi: 10.1016/j.drugpo.2004.10.002

International Journal of Drug Policy
Volume 16, Issue 3 , Pages 176-182 , June 2005